Aggressive Lymphoma Workshop - Ematologialasapienza.it...02.30 pm Welcoming remarks and introduction...
5
President: Pier Luigi Zinzani Co-President: Michele Cavo Honorary President: Sante Tura Aggressive Lymphoma Workshop Bologna, Royal Hotel Carlton May 13-14, 2019
Transcript of Aggressive Lymphoma Workshop - Ematologialasapienza.it...02.30 pm Welcoming remarks and introduction...
President: Pier Luigi Zinzani
Co-President: Michele Cavo
Honorary President: Sante Tura
Aggressive Lymphoma Workshop
Bologna, Royal Hotel Carlton
May 13-14, 2019
Faculty
Jeremy S. Abramson Boston, USA
Ranjana Advani Stanford, USA
Stephen M. Ansell Rochester, USA
Lodovico Balducci Tampa, USA
Franco Cavalli Bellinzona, Switzerland
Bruce D. Cheson Washington, USA
Paolo Corradini Milan, Italy
Leo I. Gordon Chicago, USA
Martin Hutchings Copenhagen, Danmark
Wojciech Jurczak Kraków, Poland
Issa F. Khouri Houston, USA
Won Seog Kim Seoul, Korea
John Kuruvilla Toronto, Canada
Maurizio Martelli Rome, Italy
Michel Meignan Créteil, France
Ari M. Melnick New York, USA
Jean-Marie Michot Villejuif, France
Sattva S. Neelapu Houston, USA
Owen A. O’ Connor New York, USA
Laura Pasqualucci New York, USA
Ruth Pettengell London, United Kingdom
Antonio Pinto Naples, Italy
Umberto Ricardi Turin, Italy
Davide Rossi Bellinzona, Switzerland
Simon Rule Plymouth, United Kingdom
Elena Sabattini Bologna, Italy
Julia Scarisbrick Birmingham, United Kingdom
Stephen Schuster Philadelphia, USA
David W. Scott Vancouver, Canada
Laurie H. Sehn Vancouver, Canada
Margaret Shipp Boston, USA
Carole Soussain Saint-Cloud, France
Michele Spina Aviano-PN, Italy
Louis M. Staudt Bethesda, USA
Umberto Vitolo Turin, Italy
Wyndham H. Wilson Bethesda, USA
Thomas E. Witzig Rochester, USA
Anas Younes New York, USA
Pier Luigi Zinzani Bologna, Italy
3
Requested Auspices
ALMA MATER STUDIORUMUNIVERSITÀ DEGLI STUDI DI BOLOGNA
REGIONE EMILIA-ROMAGNA
AZIENDA OSPEDALIERO-UNIVERSITARIADI BOLOGNA
AIL ASSOCIAZIONE ITALIANA CONTROLE LEUCEMIE - LINFOMI E MIELOMASEZIONE DI BOLOGNA
SIE - SOCIETÀ ITALIANA DI EMATOLOGIA
SIES - SOCIETÀ ITALIANA DI EMATOLOGIA SPERIMENTALE
02.30 pm Welcoming remarks and introduction
SESSION I: Histopathology, biology and…other Chairman: E. Sabattini
02.50 pm Histology E. Sabattini
03.10 pm Epigenetic evolution in lymphoma A.M. Melnick
03.30 pm Genetic landscape of DLBCL L. Pasqualucci
03.50 pm Mechanism-based therapy of DLBCL L.M. Staudt
04.10 pm Use of circulating tumor DNA
to genotype aggressive lymphomas D. Rossi
DIFFUSE LARGE B-CELL LYMPHOMA
SESSION II: Precision medicine Chairmen: M. Shipp, A. Younes
04.30 pm Genomic classification of DLBCL: implications for precision medicine L.M. Staudt
04.50 pm Practical considerations for using genome sequencing data for patient selection D.W. Scott
05.10 pm Molecular predictors of response M. Shipp
05.30 pm Precision medicine in the era of combination therapy: introduction to the MasterLymph protocol A. Younes
SESSION III: Double hit and double espressor lymphoma Chairman: W.H. Wilson
05.50 pm The laboratory challenge D.W. Scott
06.10 pm The clinical challenge of double hit lymphoma W.H. Wilson
06.30 pm The clinical challenge of double espressor lymphoma B.D. Cheson
SESSION IV: Update on frontline treatments and other Chairmen: L.H. Sehn, U. Vitolo
08.30 am How to treat early stage DLBCL L.H. Sehn
08.50 am Advanced stage: moving beyond R-CHOP? - the addition of ibrutinib A. Younes
- the addition of lenalidomide T.E. Witzig
09.30 am How to treat elderly patients L. Balducci
09.50 am Why doesn’t everyone respond? Primary and secondary resistance to signaling pathway W.H. Wilson
SESSION V: Specific therapeutical approaches in DLBCL and novel diagnostic Chairman: S.M. Ansell
10.10 am Role of radiotherapy U. Ricardi
10.25 am Transplant I. Khouri
10.40 am Innovative imaging tools M. Meignan
10.55 am Coffee break
SESSION VI: CAR T-cell Chairman: P. Corradini
11.10 am Juliet Study S. Schuster
11.30 am Transcend Study J.S. Abramson
11.50 am ZUMA-1 Study S.S. Neelapu
Monday May 13, 2019 Tuesday May 14, 2019
54
SESSION VII: New Drugs in DLBCL (I) Chairmen: B.D. Cheson, A. Pinto
12.10 pm ADCT-402 O.A. O’Connor
12.25 pm CC-122 J.M. Michot
12.40 pm Polatuzumab vedotin L.H. Sehn
12.55 pm Checkpoint inhibitors S.M. Ansell
01.10 pm Pixantrone R. Pettengell
01.25 pm Brentuximab vedotin J.S. Abramson
01.40 pm Lunch
SESSION VIII: New drugs in DLBCL (II) Chairmen: F. Cavalli, M. Spina
02.45 pm Umbralisib O.A. O’Connor
03.00 pm Copanlisib W.S. Kim
03.15 pm MOR208 W. Jurczak
03.30 pm TAK-659 L.I. Gordon
03.45 pm Selinexor J. Kuruvilla
04.00 pm Biosimilar Rituximab W. Jurczak
04.15 pm Hu5F9-G4 and Rituximab R. Advani
04.30 pm Bispecific monoclonal antibodies M. Hutchings
SESSION IX: Other aggressive entities and situations Chairmen: R. Advani, M. Martelli
04.45 pm Cutaneos T-cell lymphoma J. Scarisbrick
05.00 pm Burkitt lymphoma J.S. Abramson
05.15 pm Primary mediastinal Large B cell lymphoma P.L. Zinzani
05.30 pm Mantle cell lymphoma S. Rule
05.45 pm Peripheral T-cell lymphoma R. Advani
06.00 pm NK/T-cell lymphoma W.S. Kim
06.15 pm Primary CNS C. Soussain
06.30 pm Conclusions and arrivederci
MEETING VENUERoyal Hotel CarltonVia Montebello, 8 - 40121 Bologna, ItalyPhone +39 051 249361 - Fax +39 051 249724www.royalhotelcarltonbologna.com
OFFICIAL LANGUAGEEnglish
REGISTRATION FEEEuro 250,00 (Italian VAT included)The registration fee includes: conference kit, participation in the scientific sessions, attendance certificate, coffee break, lunch, slides of the meeting.
BADGEAll registered participants, speakers and sponsors will be given a badge which they must wear to be admitted to the scientific sessions.
CERTIFICATE OF ATTENDANCEA certificate will be given to all participants at the end of the meeting.
ITALIAN CME CREDITSAn Italian CME application has been submitted as follows:- Provider Studio ER Congressi SRL: ID 828-246084.- No. 8,4 CME credits for Physicians (disciplines: Hematology, Oncology, Radiotherapy, Pathological Anatomy, Clinical Pathology) and Biologists.- Educational objective: “linee guida-protocolli-procedure”.
EUROPEAN CME CREDITSThe program of the “Aggressive Lymphoma Workshop” has been reviewed and approved for CME accreditation by the European Board for Accreditation in Hematology (EBAH), an inde-pendent accreditation body endorsed by EHA. The EBAH Unit has approved this educational activity for no. 12 CME credits for Physicians and Biologists. To request credits, please fill out the form and return it to the registration desk at the end of the meeting. We remind you that it is necessary to have an EBAH-CME account in order to claim for credits.Attendees can create an EBAH-CME account registering on the website: http://ebah.org even on site.
CHANGESParts of the program may be changed without notice.
Tuesday May 14, 2019 General Information
76
stru
chel
.com
Scientific Secretariat
Pier Luigi ZinzaniIstituto di Ematologia “Lorenzo e Ariosto Seràgnoli”Via Massarenti, 9 - 40138 Bologna, ItalyPhone +39 051 2143680 Fax +39 051 2144037E-mail: [email protected]
Organizing Secretariat
Studio E.R. CongressiVia Marconi, 36 - 40122 Bologna, ItalyPhone +39 051 4210559Fax +39 051 4210174E-mail: [email protected]
![arXiv:1705.07251v1 [physics.soc-ph] 20 May 2017 · PACS numbers: 89.75.Hc, 02.50.-r I. INTRODUCTION Much research has focused in recent years on a wide ... indirect proxies. In [24]](https://static.fdocuments.us/doc/165x107/5e7d2bc16f39fa60b877a8a5/arxiv170507251v1-20-may-2017-pacs-numbers-8975hc-0250-r-i-introduction.jpg)
